For research use only. Not for therapeutic Use.
Smilagenin acetate is a sapogenin derivative extracted from patent US20030004147A1. Smilagenin acetate increases the expression of acetylcholine m2 receptors and can be used for the research of dementia[1].
Smilagenin acetate increases the expression of m2 receptors on CHO cells transfected with DNA for the m2 receptor[1].
| Catalog Number | I044914 |
| CAS Number | 4947-75-5 |
| Synonyms | [(1R,2S,4S,5’R,6R,7S,8R,9S,12S,13S,16S,18R)-5′,7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2′-oxane]-16-yl] acetate |
| Molecular Formula | C29H46O4 |
| Purity | ≥95% |
| InChI | InChI=1S/C29H46O4/c1-17-8-13-29(31-16-17)18(2)26-25(33-29)15-24-22-7-6-20-14-21(32-19(3)30)9-11-27(20,4)23(22)10-12-28(24,26)5/h17-18,20-26H,6-16H2,1-5H3/t17-,18+,20-,21+,22-,23+,24+,25+,26+,27+,28+,29-/m1/s1 |
| InChIKey | LVRAKYNQYKVPIK-BSPYNPCNSA-N |
| SMILES | CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CCC6C5(CCC(C6)OC(=O)C)C)C)C)OC1 |
| Reference | [1]. Paul Barraclough, et al. 5-beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia. US20030004147A1. |
